Mesylate apatinib combined with chemotherapy in the treatment of clinical study of osteosarcoma recurrence and metastasis
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- 03 Mar 2017 New trial record